Our protocol accelerates access to potent regenerative therapies, delivering safe, consistent, and transformative outcomes for those with even the most intractable sleep disorders [16-20]
Furthermore, eight out of nine preclinical studies evaluated in this meta-analysis showed that a KD was able to slow down tumor growth, often even as a monotherapy
Melatonin, mitochondria, and the skin
This evidence might suggest the additional specific points to be considered for the demonstrated spontaneous release of NO [49,67,68], activated phosphorilazation of eNOS [61], counteraction of the adverse effect of NOS-blockade (i.e., L-NAME hypertension and pro-thrombotic effect), and counteraction of the adverse effect of NOS overstimulation (i.e., L-arginine hypertension and anti-thrombotic effect) [49,67,69]